no code implementations • 2 Dec 2023 • Lian Zhang, Jason M. Holmes, Zhengliang Liu, Hongying Feng, Terence T. Sio, Carlos E. Vargas, Sameer R. Keole, Kristin Stützer, Sheng Li, Tianming Liu, Jiajian Shen, William W. Wong, Sujay A. Vora, Wei Liu
The noisy probing dose method showed better generalizability in the 6 outlier cases than the ROI-based and beam mask-based methods with 3D Gamma passing rates (for prostate cancer, targets: 89. 32%$\pm$1. 45% vs. 93. 48%$\pm$1. 51% vs. 96. 79%$\pm$0. 83%, OARs: 85. 87%$\pm$1. 73% vs. 91. 15%$\pm$1. 13% vs. 94. 29%$\pm$1. 01%).